$LOVFF News

Last published 2mo ago

2mo agoLOVFFCannara Expands Financing to an $80 Million Syndicated Credit Facility with BMO and TD Bank, Further Strengthening Its Financial Foundation for Continued GrowthGlobeNewswireMONTREAL, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara", the "Company", "us" or "we") (TSX:LOVE) (OTCQX:LOVFF) (FRA: 8CB0), a vertically integrated producer of
2mo agoLOVFFCannara Appoints Nicholas Fozard as Chief Financial OfficerGlobeNewswireMONTREAL, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara", the "Company", "us" or "we") (TSX:LOVE) (OTCQX:LOVFF) (FRA: 8CB0), a vertically integrated producer of
3mo agoLOVFFCannara Establishes Automatic Share Purchase PlanGlobeNewswireMONTREAL, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara", the "Company", "us" or "we") (TSX:LOVE) (OTCQX:LOVFF) (FRA: 8CB0), a vertically integrated producer of
3mo agoLOVFFCannara Announces Normal Course Issuer BidGlobeNewswireMONTREAL, July 22, 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara", the "Company", "us" or "we") (TSX:LOVE) (OTCQX:LOVFF) (FRA: 8CB0),a vertically integrated producer of
3mo agoLOVFFCannara Reports Record Q3 Revenues and Continued Profitability Accompanied By Expanding National Distribution and Accelerated Capacity ExpansionGlobeNewswireDelivered strong Q3 financial results: Generated $31.8 million in total net revenues, $13.4 million in gross profit before fair value adjustments, or 42% of revenues, $8.5 million in adjusted EBITDA1, and $5.7 million
4mo agoLOVFF CURLFCannara Announces a Long-Term International Cannabis Supply Agreement with Curaleaf International LimitedGlobeNewswireMONTREAL, July 14, 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara", the "Company", "us" or "we") (TSX:LOVE) (OTCQX:LOVFF) (FRA: 8CB0), a vertically integrated producer of
4mo agoLOVFFCannara to Announce Fiscal Q3 2026 Financial Results on July 15, 2026GlobeNewswireMONTREAL, July 08, 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara", the "Company", "us" or "we") (TSX:LOVE) (OTCQX:LOVFF) (FRA: 8CB0), a vertically integrated producer of
4mo agoLOVFFCannara Secures Exclusive Canadian Rights to Blue River's Ampersand™ Live Rosin Infusion TechnologyGlobeNewswireMONTREAL, July 02, 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara", the "Company", "us" or "we") (TSX:LOVE) (OTCQX:LOVFF) (FRA: 8CB0), a vertically integrated producer of
6mo agoLOVFFCannara Completes Acquisition of Medican Organic Inc.GlobeNewswireMONTREAL, May 06, 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara", the "Company", "us" or "we") (TSX:LOVE) (OTCQX:LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis products at
7mo agoLOVFFCannara Reports Q2 Fiscal 2026 Results with Continued Profitability, Strong Operating Cash Flow and #1 Retail Market Share in QuébecGlobeNewswireDelivered strong Q2 financial results: Generated $27.2 million in total net revenues, $11.6 million in gross profit before fair value adjustments or 43% of revenues, $6.0 million in adjusted EBITDA1, and $2.9 million in
7mo agoLOVFFCannara to Announce Fiscal Q2 2026 Financial Results on April 14, 2026GlobeNewswireMONTREAL, April 07, 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara", "the Company", "us" or "we") (TSX:LOVE) (OTCQX:LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis products at
8mo agoLOVFFCannara Announces Graduation to the Toronto Stock ExchangeGlobeNewswireMONTREAL, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara", "the Company", "us" or "we") (TSXV:LOVE) (OTCQX:LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis products at
9mo agoLOVFFCannara to Host Investor Webcast on February 19th, 2026GlobeNewswireMONTREAL, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara", "the Company", "us" or "we") (TSXV:LOVE) (OTCQX:LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis products at
9mo agoLOVFFCannara Announces Strategic C$6.3 Million Non-Brokered Private Placement Priced at C$2.10 per Common ShareGlobeNewswireMONTREAL, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara", "the Company", "us" or "we") (TSXV:LOVE) (OTCQX:LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis products at
9mo agoLOVFFCannara Announces Conditional Approval to List on the Toronto Stock ExchangeGlobeNewswireMONTREAL, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara", "the Company", "us" or "we") (TSXV:LOVE) (OTCQX:LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis products at
9mo agoLOVFFCannara Reports Q1 Fiscal 2026 Results, Delivers New Record Financial Results, Extends Market Share Gains and Advances Disciplined Expansion StrategyGlobeNewswireNew Record Financial Results: Total revenues of $30.1 million, gross profit before fair value adjustments of $13.5 million or 45% and Adjusted EBITDA of $8.8 million1, supported by operating cash flows of $8.0 million
10mo agoLOVFFCannara Achieves OTCQX Qualification and Announces Release of Fiscal Q1 2026 Financial Results on January 26, 2026GlobeNewswireMONTREAL, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara", "the Company", "us" or "we") (TSXV:LOVE) (OTCQX:LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis products at
10mo agoLOVFF OTCMOTC Markets Group Welcomes Cannara Biotech Inc. to OTCQXGlobeNewswireNEW YORK, Jan. 14, 2026 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX:OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Cannara Biotech Inc. (TSXV:LOVE,
10mo agoLOVFFCannara Achieves #1 Market Share Position in Québec as of December 2025 and Provides Update on Québec Vape Category LaunchGlobeNewswireMONTREAL, Québec, Jan. 02, 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara", "the Company", "us" or "we") (TSXV:LOVE) (OTCQB:LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis
11mo agoLOVFFCannara Biotech Delivers Record Fiscal 2025 Revenue and Profitability, Achieves First Year of Positive Retained EarningsGlobeNewswireRecord Fiscal 2025 Financial Performance: Record net revenues of $107.3 million, adjusted EBITDA of $28.1 million1, net income of $13.1 million, operating cash flow of $20 million and free cash flow of $13.7 million1 for
11mo agoLOVFFCannara Biotech Inc. to Announce Fiscal Q4 2025 and Fiscal Year 2025 Financial Results on November 24, 2025 and Provides Board UpdateGlobeNewswireMONTREAL, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara", "the Company", "us" or "we") (TSXV:LOVE) (OTCQB:LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis products at
1y agoLOVFFCannara Announces DTC Eligibility to Facilitate U.S. Investor Access and Strengthens Balance Sheet through completion of Debt-to-Equity ConversionGlobeNewswireMONTREAL, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara", "the Company", "us" or "we") (TSXV:LOVE) (OTCQB:LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis products at
1y agoLOVFFCannara Announces Proposed Settlement of Convertible Debenture via Share IssuanceGlobeNewswireMONTREAL, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara", "the Company", "us" or "we") (TSXV:LOVE) (OTCQB:LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis products at
1y agoLOVFFCannara Announces Grant of Options and RSUsGlobeNewswireMONTREAL, Sept. 01, 2025 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara", "the Company", "us" or "we") (TSXV:LOVE) (OTCQB:LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis products at
1y agoLOVFFCannara Announces Amendment and Upsize of BMO Credit Facility to Support Facility Expansion at ValleyfieldGlobeNewswireMONTREAL, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara", "the Company", "us" or "we") (TSXV:LOVE) (OTCQB:LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis products at
1y agoLOVFFCannara Biotech Enhances Financial Flexibility Through Strategic Asset SaleGlobeNewswireMONTREAL, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara", "the Company", "us" or "we") (TSXV:LOVE) (OTCQB:LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis products at
1y agoLOVFFCannara Biotech Delivers Highest Revenue and Profitability Since Inception in Fiscal Q3 2025GlobeNewswireRecord Revenue: Total revenues, net of excise taxes increased to $27.3 million in Q3 2025, representing a 40% increase over the prior year period.Record Profitability: Gross profit before fair value adjustments rose to
1y agoLOVFFCannara Secures 5 Key Listings in Québec's New Vape Cartridge Category Including to be Released Live Rosin VapesGlobeNewswireMONTREAL, July 24, 2025 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara", "the Company", "us" or "we") (TSXV:LOVE) (OTCQB:LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis products at
1y agoLOVFFCannara Biotech Inc. to Announce Fiscal Q3 2025 Financial Results on July 28, 2025GlobeNewswireMONTREAL, July 21, 2025 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara", "the Company", "us" or "we") (TSXV:LOVE) (OTCQB:LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis products at
1y agoLOVFFCannara Biotech to Host Investor Webcast on June 25th, 2025GlobeNewswireMONTREAL, June 19, 2025 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara", "the Company", "us" or "we") (TSXV:LOVE) (OTCQB:LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis products at
1y agoLOVFFCannara Reduces Cost of Debt with Lower Interest Rate and Partial Debenture Repayment; Wins 2025 Brand of the YearGlobeNewswireMONTREAL, June 18, 2025 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara", "the Company", "us" or "we") (TSXV:LOVE) (OTCQB:LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis products at
1y agoLOVFFCannara Biotech Delivers Record Q2 Results as National Expansion AcceleratesGlobeNewswireRecord Revenue: Net revenues of $26.6 million in Q2 2025, a 35% increase compared to $19.7 million in Q2 2024, driven by national brand growth and product innovation.Record Profitability: Gross profit before fair value
1y agoLOVFFCannara Biotech Inc. to Announce Fiscal Q2 2025 Financial Results on April 28, 2025GlobeNewswireMONTREAL, April 16, 2025 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara", "the Company", "us" or "we") (TSXV:LOVE) (OTCQB:LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis and
1y agoLOVFFCannara Biotech Announces Appointment of Justin Cohen to Board of DirectorsGlobeNewswireMONTREAL, March 24, 2025 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara", "the Company", "us" or "we") (TSXV:LOVE) (OTCQB:LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis and
1y agoLOVFFCannara Biotech to Present at The Ventum Canadian Cannabis Conference on March 12th, 2025GlobeNewswireMONTREAL, March 06, 2025 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara", "the Company", "us" or "we") (TSXV:LOVE) (OTCQB:LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis and
1y agoLOVFFCannara Announces Extension of BMO Credit Facility and Convertible Debenture to Enhance Financial Flexibility and Support Execution of its Long-Term StrategyGlobeNewswireMONTREAL, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara", "the Company", "us" or "we") (TSXV:LOVE) (OTCQB:LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis and derivative
1y agoLOVFFCannara Biotech Reports Record Q1 2025 Revenue and National Market Share, Sets Stage for Continued Momentum in 2025GlobeNewswireRecord Revenue: Net revenues of $25.1 million in Q1 2025, a 29% increase compared to $19.5 million in Q1 2024, driven by strong demand for Cannara's premium-grade cannabis products.Record Market Share: Achieved Canadian
1y agoLOVFFCannara Provides Update on Its 2024 Annual General Meeting Materials amid Canada Post StrikeGlobeNewswireMONTREAL, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara", "the Company", "us" or "we") (TSXV:LOVE) (OTCQB:LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis and derivative
1y agoLOVFFCannara Biotech to Host Investor Webcast on Thursday December 19th, 2024GlobeNewswireMONTREAL, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara", "the Company", "us" or "we") (TSXV:LOVE) (OTCQB:LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis and derivative
1y agoLOVFFCannara Biotech Inc. Reports Q4 and Fiscal Year 2024 Results: Achieves Record Sales Growth and Operating Cash Flow, Solidifying Leadership in Canada's Cannabis MarketGlobeNewswireRecord Q4 and year-end total revenues of $23.4 million and $82.2 million, representing a 28% and 43% increase compared to the same periods in 2023.Robust growth in Q4 over Q3 2024, with total revenues increasing by 20%,
2y agoLOVFFCannara Biotech Achieves its Highest National Market Share of 3.2% in July 2024 and Announces Investor Webcast Scheduled for August 20, 2024GlobeNewswireMONTREAL, Aug. 16, 2024 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV:LOVE) (OTCQB:LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis and
2y agoLOVFFCannara Biotech Reports Q3 2024 Financial ResultsGlobeNewswireGross cannabis revenues before excise taxes increased to $26.2 million in Q3 2024 from $20.6 million in Q3 2023, a $5.6 million or 27.6%, increase. Total revenues, net of excise taxes, increased to $19.5 million in Q3
3y agoLOVFFCannara Biotech Inc. Reports Record Q3 2023 Financial Results with Net Revenues of $15.9 Million and Net Income of $2.9 millionPR NewswireThree- and nine-month net revenue were $15.9 million and $39.3 million, a 57% and 63% increase compared to the same periods of prior year Delivered its ninth consecutive quarter of positive Adjusted EBITDA of $3.9
3y agoLOVFFCannara Biotech Inc. To Participate At Canaccord Genuity's 7th Annual Global Cannabis ConferencePR NewswireMONTREAL, May 11, 2023 /CNW/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV:LOVE) (OTCQB:LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative product
3y agoLOVFFCANARA BIOTECH INC. SECURES AN ADDITIONAL $10 MILLION IN NON-DILUTIVE CAPITAL WITH ITS LEAD CREDIT PROVIDER, BMO COMMERCIAL BANKINGPR NewswireMONTREAL, May 4, 2023 /CNW/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV:LOVE) (OTCQB:LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative product
3y agoLOVFFCannara Biotech Inc. to Host Investor Webcast on May 4th, 2023PR NewswireMONTREAL, April 25, 2023 /CNW/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV:LOVE) (OTCQB:LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative product
3y agoLOVE LOVFFCannara Biotech Inc. reports Q2 2023 Financial Results with quarterly net revenues of $13 million, a 76% increase compared to Q2 2022PR NewswireSix-month net revenues of $23.4 million, a 67% increase compared to first half 2022 Delivered its eighth consecutive quarter of positive Adjusted EBITDA of $3.2M, a 1500% increase compared to Q2 2022 Continued to
3y agoLOVFFCannara Biotech Inc. Enters into an Automatic Share Purchase PlanPR NewswireMONTREAL, Feb. 28, 2023 /PRNewswire/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV:LOVE) (OTCQB:LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative
3y agoLOVFFCANNARA BIOTECH INC. ANNOUNCES RESULTS OF ANNUAL SHAREHOLDER MEETING AND CONVERSION INTO EQUITY OF A $5M CONVERTIBLE DEBENTURE AT $0.18 CENT PER COMMON SHAREPR NewswireMONTREAL, Feb. 10, 2023 /PRNewswire/ - Cannara Biotech Inc. ("Cannara" or the "Company") ((
3y agoLOVFFCannara Biotech Inc. Reports Q1 2023 Financial ResultsPR NewswireCompany recorded $10.3 million in quarterly revenue; a 57% increase compared to Q1 2022 Delivered its seventh consecutive quarter of positive Adjusted EBITDA of $1.7M and reported positive net income for a second